FFO
IMMX icon

Fortitude Family Office’s Immix Biopharma IMMX Stock Holding History

Fortitude Family Office’s Portfolio IMMX Stock Details IMMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-53
Closed -$483 – 2320
2026
Q1 		$483 Buy
+53
New +$389 ﹤0.01% 1743

Other funds holding IMMX

PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
AP
Aspect Partners Fairfax, Virginia $268M AUM 22.57% 1-Year Est. Return

Fortitude Family Office's IMMX Position: Q2 2026 in Review

Fortitude Family Office sold out of Immix Biopharma (IMMX) in Q2 2026, closing a stake of 53 shares — an estimated $483 sold.

Fortitude Family Office first reported a position in IMMX in Q1 2026 and held it in 1 quarter. The position peaked at $483 in Q1 2026. 4 funds tracked by Wall St. Rank hold IMMX as of Q2 2026.

  • Fortitude Family Office reported no remaining Immix Biopharma position as of Q2 2026 after selling out during the quarter.
  • Fortitude Family Office sold 53 Immix Biopharma shares in Q2 2026, an estimated $483.
  • Fortitude Family Office first reported a position in Immix Biopharma in Q1 2026 and held it in 1 quarter.
  • Fortitude Family Office's Immix Biopharma position peaked at $483 in Q1 2026.
  • 4 funds tracked by Wall St. Rank held Immix Biopharma as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.